MedPath

Rapastinel

Generic Name
Rapastinel
Drug Type
Small Molecule
Chemical Formula
C18H31N5O6
CAS Number
117928-94-6
Unique Ingredient Identifier
6A1X56B95E

Overview

Rapastinel has been used in trials studying the treatment of Depressive Disorder, Major and Obsessive-Compulsive Disorder (OCD).

Background

Rapastinel has been used in trials studying the treatment of Depressive Disorder, Major and Obsessive-Compulsive Disorder (OCD).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)
Phase 3
Withdrawn
Posted: 2019/02/27
Sponsor:
Naurex, Inc, an affi...
ID:NCT03855865
Assessment of Effect of Rapastinel on Driving Performance
Phase 1
Completed
Posted: 2019/01/24
Sponsor:
Naurex, Inc, an affi...
ID:NCT03814733
Assessment of Abuse Potential of Rapastinel in Humans
Phase 1
Completed
Posted: 2019/01/10
Sponsor:
Naurex, Inc, an affi...
ID:NCT03799900
Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)
Phase 3
Terminated
Posted: 2018/09/18
Sponsor:
Naurex, Inc, an affi...
ID:NCT03675776
Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)
Phase 3
Terminated
Posted: 2018/09/12
Sponsor:
Naurex, Inc, an affi...
ID:NCT03668600

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy